|
|
||||||||
Original Research Communications |
See related article on page 272.
| ABSTRACT |
|---|
|
|
|---|
Objective: We aimed to characterize the relation between BMI and stature and risk of different types of cataract.
Design: We analyzed data from participants in the Salisbury Eye Evaluation (SEE), a cross-sectional survey of visual status and demographic, nutritional, and environmental factors conducted between 1993 and 1995 in a representative sample of community-dwelling older persons in Salisbury, MD. Multiple logistic regression techniques were used to compare risk factors between individuals with nuclear, cortical, or posterior subcapsular (PSC) opacities and individuals with no cataract.
Results: Risk of nuclear opacification was greater in participants with lower BMIs [adjusted odds ratio of 1.13 (95% CI: 1.02, 1.27) with a BMI of 22.5 compared with 28.0] and of taller stature [1.12 (95% CI: 1.01, 1.25) with a stature of 170.5 cm compared with 164]. In contrast, risk of cortical opacification was greater in participants with higher BMIs and of taller stature, but the relation for stature diminished in magnitude and was not significant after adjustment for other risk factors. BMI was not related to risk of PSC opacities, but there was some evidence that taller stature is a risk factor for PSC opacification (P = 0.06) after adjustment for other risk factors.
Conclusions: Both BMI and stature are independent risk factors for cataracts in the SEE population, with the nature of the risk dependent on cataract type.
Key Words: Body mass index BMI stature weight elderly cataract Salisbury Eye Evaluation posterior subcapsular opacity
| INTRODUCTION |
|---|
|
|
|---|
Previous research has identified many risk factors for age-related cataract, including injury, environment, disease, and nutrition-related factors (4, 5). In various studies, cataract risk has been shown to increase with older age, race, diabetes, hypertension, smoking, alcohol use, and low socioeconomic status or educational attainment. Variation in body mass index (BMI; in kg/m2) has also been shown to influence cataract risk, although there is no consensus on the direction or nature of the association. Both higher (6) and lower (710) BMIs have been associated with increased risk of cataract. It is difficult to conclude much about the role of BMI in cataract formation for several reasons. First, lower BMIs are associated with smoking, alcohol consumption, and lower socioeconomic status, whereas higher BMIs are associated with African American race, diabetes, hypertension, and other morbidities, all of which also influence risk of cataract. Second, the etiologies of cataract differ by cataract type, and not all studies have examined whether the relation of BMI with cataract depends on the cataract type. Finally, BMI is a measure of body size, and although independent of height or stature, it makes sense to consider other indicators of body size, such as height or stature, as potential risk factors for cataract. The purpose of the present study was to assess whether BMI and stature are risk factors for cataract and specific cataract type in older men and women enrolled in The Salisbury Eye Evaluation (SEE), in whom other risk factors for cataract were also measured.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
The sample was selected from the US Health Care Financing Administration Medicare Database, which includes 98% of persons aged
65 y. At the time of recruitment, there were 7004 Salisbury residents 6584 y of age; of these, 18.4% were African American and 81.6% were white. For the study, all the African American and a random, age-stratified sample of white participants were selected (56% of those aged 6574 y and 62% of those aged 7584 y). Institutionalized or housebound individuals (n = 155) and those who scored
17 on the Mini-mental state exam (12; n = 103) were excluded from the study. Of the 3906 eligible persons, 1020 (26%) refused to participate or could not be located (11).
To determine visual function, a 4-h examination was performed at the SEE clinic. As described by West et al (13), each subject's pupils were dilated and lens photographs were taken. Two nuclear photographs were taken with a photo slit lamp (SL-5D; Topcon, Tokyo) with the slit beam set at a height of 9 mm and a width of 0.1 mm and angled at 40°. Cortical photographs were taken with a retroillumination camera (Neitz, Inc, Tokyo) focused just posterior to the pupillary margin. A distance-recording device was set to zero at that point. Photographs were then taken of the posterior subcapsular (PSC) region of the lens, and the focusing distance to the back of the lens was measured. All photographs were processed by using standard processing techniques (Wilmer Photographic Services, Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore) and photographs of each eye were evaluated separately.
Photographs were graded for type and severity of opacity by using the Wilmer grading scheme (14). Nuclear opacification was graded using a photographic standard as described by Bailey et al (15) and cortical opacification was estimated using the method developed by West et al (16). PSC opacities were graded as present or absent and if present, by the maximum height and width. All photographs were graded independently by 2 trained graders; in the event of disagreement a third grading was performed. A standard panel of 53 photographs was circulated among the photographs during the grading process and both intra- and interobserver variations were calculated. The weighted
statistics for interobserver variation in the grading of the nuclear and cortical photographs were >0.90, indicating excellent agreement.
Standard definitions were used to determine cataract status. Nuclear opacity was defined as follows: for density, on a scale of 0.04.0, the presence of grade
2.0 in the photographs of at least one eye; for cortical opacity, measured as percentage area (in sixteenths) affected, the presence of grade
4/16 in the photographs of at least one eye. A PSC opacity was considered present if all 3 graders agreed. Subjects were considered to have opacity if at least one eye had any of the 3 types of cataract (nuclear, cortical, and PSC). If a participant had unilateral surgery or ungradeable photographs in one eye, the other eye was used to determine opacity grade. Two hundred forty-five participants had bilateral cataract surgery before enrollment and were excluded from the analyses.
During the clinic examination, each participant's weight and stature were measured by trained observers. For analyses, BMI and stature were treated as continuous as well as categoric variables divided into categories based on the deciles of their respective distributions. Information on other risk factors was obtained from the participants during the home interview. The variables examined during analyses included participants' age (in y), sex, race (white or African American), smoking habit, energy intake, alcohol consumption, exposure to ultraviolet-blue (UV-B), and presence or absence of diabetes, hypertension, and other significant morbidities. Energy intake was estimated by using the dietary intake portion (long version) of the Health Habits and History Questionnaire of the National Cancer Institute (17, 18). Exposure to UV-B was assessed over each individual's lifetime and divided by their exact age to give their average annual UV-B exposure (19, 20). Self reports of diabetes and hypertension were verified by assessing the subjects' medical records, glycosylated hemoglobin or blood pressure values during the clinical exam, or use of specific medications. New cases of diabetes were identified as those having glycosylated hemoglobin values 2 SDs above their age- and sex-specific means, and new cases of hypertension were identified by a blood pressure >160/90 mm Hg.
Of 2886 SEE participants, 2520 completed the clinical exam involving the vision tests. Of these, 374 were excluded because of bilateral surgery (n = 245), nondilatation, or ungradeable photos. Of 2146 participants with gradeable eye data, 1976 provided complete data on known risk factors for cataract except for UV-B exposure, which was available for only 1943 subjects.
The characteristics of the SEE participants were described across age and sex groups. The distributions of specific risk factors for cataract across BMI and stature were examined by using analysis of variance and chi-square tests as appropriate. The crude and adjusted effects on each cataract type of variation in BMI, stature, and other risk factors were estimated by using logistic regression, and were described as odds ratios (ORs) with 95% CIs. In these models, we sought to identify risk factors for each cataract type compared with no cataract at all; therefore, the exposure status of 826 cases of nuclear, 250 cases of cortical, and 95 cases of PSC were compared (in 3 separate models) to the exposure status of 949 individuals with no cataract. Subjects with multiple types of cataract (n = 44) were counted as cases for each type of cataract as appropriate. To illustrate the range of differences in cataract risk associated with BMI, ORs were calculated for every 5.5 kg/m2 from the mean BMI (28) across ±2 SDs of BMI in the population (±11). For stature, ORs were calculated for every 6.5 cm from the mean stature (164 cm) across ±2 SD of stature (±13 cm).
| RESULTS |
|---|
|
|
|---|
27, whereas African American women had an average BMI of 31.
|
4/16, and 57% had PSC opacities. In contrast, only 2433% of African Americans had nuclear opacities, but 2428% had cortical opacities. African Americans were about one-half as likely as white subjects to have PSC opacities.
As expected, variation in BMI was associated with variation in other known risk factors for age-related cataracts (Table 2
). Lower BMI was associated with older age, female sex, and current smoking and alcohol consumption. Individuals with a BMI <22 or >27.9 were more likely to be African American and to be less educated. The prevalences of both diabetes and hypertension were greater in those with higher BMIs. There was no difference in UV-B exposure across BMI categories.
|
|
The ORs relating variation in stature to risk of cataract estimated from the same regression models are shown in Table 4
. Shorter SEE participants were at significantly greater risk for nuclear and cortical cataract; however, after adjustment, stature was associated with risk of nuclear opacities onlyand in the opposite direction. In crude analyses, taller stature was associated with greater risk of PSC opacities, but the trend was not significant. After adjustment for BMI and other risk factors, the positive relation between stature and PSC opacities became stronger and was marginally significant (P = 0.06).
|
| DISCUSSION |
|---|
|
|
|---|
In contrast, risk of cortical opacities appeared to be greater in those with higher BMIs. The magnitude of the relation was similar to that observed for nuclear opacities, and it was not diminished after adjustment for other known risk factors in the multivariate analyses. Neither BMI nor stature is related to PSC opacities. The results are clear for BMI; however, sample size may have been a limiting factor for stature. No relation between stature and PSC opacity was observed during crude analyses, but after adjustment for other known risk factors (in particular female sex) the positive relation between stature and PSC opacity risk became strong in magnitude but was not significant.
Our results are consistent with most studies relating BMI and cataract risk in other populations (710). In these studies, lower BMI was interpreted as an indicator of undernutrition or nutritional deprivation. Consistent with this etiology of deprivation, risk of cataract is greater in those with lower socioeconomic status, with fewer years of education, with poorer quality of diet, in those who smoke, and in those with a history of diarrhea and dehydration (4, 5). Furthermore, the prevalence of cataract is highest in developing countries, where cataracts develop at earlier ages (4, 5). However, many of the previous studies describing an association between BMI and cataract have been criticized for failing to consider cataract type and to adequately adjust for other indicators of poverty, such as lower education, smoking, and dietary intake. Although not shown, variation in intakes of energy and micronutrients did not influence the relations between BMI, stature, and cataract described here. Thus, our results indicate that lower BMI is a risk factor for nuclear cataract independent of other risk factors that characterize the likelihood of undernutrition. Why would a higher BMI protect against nuclear cataract? We do not know, but note that our results may indicate some sort of tradeoff in risk between nuclear and cortical cataract associated with BMI. Taken together, our results suggest that tall, thin people are at increased risk for nuclear opacities, whereas short, heavy people are at increased risk for cortical opacities. This latter association, however, can be attributed to other known risk factors for cortical opacification. Whether having one type of cataract reduces the likelihood of developing another type of cataract is not known, but the etiologies differ by cataract type, and few individuals develop more than one type of cataract (in our study, only <5%).
Note, however, that our results are in direct contrast with those reported by Glynn et al (6), who found that among participants in the Physicians' Health Study the risk of developing nuclear and PSC cataract was higher in physicians with higher BMIs. The explanation for the divergent findings by Glynn et al (6) is not clear, but several factors may play a role. In our study, we calculated BMI with actual weights and heights taken by trained personnel during a clinical exam, whereas Glynn et al (6) used reported heights and weights of persons responding to a questionnaire. The definitions of cataracts were also different. Our study used photographic documentation of lens status, graded using a standard scheme. The Physicians' Health Study relied on self-reporting confirmed with medical records and required that the cataract be responsible for a decrease in visual acuity. Thus, individuals with early cataract were not included and were part of the noncataract group. They also examined the relation of BMI with prospective incidence of cataract, whereas the other studies (including our own) examined the association between BMI and prevalence of cataract at the time of the study. Finally, the natures of the populations were quite different; in contrast with our study, the Physicians' Health Study included men only, who were substantially younger, more educated, somewhat thinner, much less likely to suffer from diabetes and cataracts, and presumably white.
To our knowledge, this was the first study to identify adult stature as a risk factor for nuclear and perhaps PSC opacities. We did not hypothesize this association a priori; rather, we considered stature as a covariate in models examining BMI as a risk factor for cataract. We present the findings for stature because they remained significant after careful examination during analyses, including multivariate adjustment for other known risk factors for each cataract type. The interpretation of these findings is not clear, but final adult stature is known to be a function of genetic factors, the early nutritional environment, and growth during adolescence. Thus, stature, as a risk factor for cataract, likely includes aspects of one or all of these factors.
In the SEE population, BMI and stature were each associated in a constant or graded fashion with variation in cataract risk. In epidemiologic terms, everyone is exposed to these anthropometric risk factors for cataract formation. Put simply, everyone has a BMI and a stature. This means that although variations in cataract risk across BMI and stature appear small, such risks can potentially translate into many cases of cataract at the population level attributable to BMI, stature, or both. This also means that shifts in the BMI distribution will also likely translate into changes in the proportion of cataract attributable to BMI in a population, if the relation is causal.
Consideration of BMI is also important because it is one of the few modifiable risk factors for cataract. Given its relation with risk of nuclear cataract in this and other studies, further research is needed to clarify the mechanism through which BMI and stature influence cataract risk and the likely change in cataract burden at the target population, given interventions to influence adult BMI. Further research is also needed on stature as a risk factor for cataract in this and other populations.
| FOOTNOTES |
|---|
2 Supported by the National Institute of Aging grant no. PO1-A10184 and the Beca de Amplicación de Estudios 1997/5062 of Fondo de Investigaciones Sanitarias del Ministerio de Sanidad y Consumo, Spain (JC-R).
3 Reprints not available. Address correspondence to LE Caulfield, Center for Human Nutrition, Johns Hopkins School of Hygiene and Public Health, Room W2041, 615 North Wolfe Street, Baltimore, MD 21205. E-mail: lcaulfie{at}jhsph.edu.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. E. Freeman, B. L. Egleston, S. K. West, K. Bandeen-Roche, and G. Rubin Visual Acuity Change and Mortality in Older Adults Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4040 - 4045. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Kuang, S.-Y. Tsai, W.-M. Hsu, C.-Y. Cheng, J.-H. Liu, and P. Chou Body Mass Index and Age-Related Cataract: The Shihpai Eye Study Arch Ophthalmol, August 1, 2005; 123(8): 1109 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Delcourt, A.-M. Dupuy, I. Carriere, A. Lacroux, J.-P. Cristol, and for the Pathologies Oculaires Liees a l'Age (POLA) Albumin and Transthyretin as Risk Factors for Cataract: The POLA Study Arch Ophthalmol, February 1, 2005; 123(2): 225 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Broman, S. K. West, B. Munoz, K. Bandeen-Roche, G. S. Rubin, and K. A. Turano Divided Visual Attention as a Predictor of Bumping while Walking: The Salisbury Eye Evaluation Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2955 - 2960. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F Jacques, S. M Moeller, S. E Hankinson, L. T Chylack Jr, G. Rogers, W. Tung, J. K Wolfe, W. C Willett, and A. Taylor Weight status, abdominal adiposity, diabetes, and early age-related lens opacities Am. J. Clinical Nutrition, September 1, 2003; 78(3): 400 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J Foster, T Y Wong, D Machin, G J Johnson, and S K L Seah Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey Br. J. Ophthalmol., September 1, 2003; 87(9): 1112 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. J. M. Berendschot, W. M. R. Broekmans, I. A. A. Klopping-Ketelaars, A. F. M. Kardinaal, G. van Poppel, and D. van Norren Lens Aging in Relation to Nutritional Determinants and Possible Risk Factors for Age-Related Cataract Arch Ophthalmol, December 1, 2002; 120(12): 1732 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Saw, W.-H. Chua, C.-Y. Hong, H.-M. Wu, K.-S. Chia, R. A. Stone, and D. Tan Height and Its Relationship to Refraction and Biometry Parameters in Singapore Chinese Children Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1408 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Freeman, B. Munoz, O. D. Schein, and S. K. West Hormone Replacement Therapy and Lens Opacities: The Salisbury Eye Evaluation Project Arch Ophthalmol, November 1, 2001; 119(11): 1687 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Worzala, R. Hiller, R. D. Sperduto, K. Mutalik, J. M. Murabito, M. Moskowitz, R. B. D'Agostino, and P. W. F. Wilson Postmenopausal Estrogen Use, Type of Menopause, and Lens Opacities: The Framingham Studies Arch Intern Med, June 11, 2001; 161(11): 1448 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Wong, P. J. Foster, G. J. Johnson, B. E. K. Klein, and S. K. L. Seah The Relationship between Ocular Dimensions and Refraction with Adult Stature: The Tanjong Pagar Survey Invest. Ophthalmol. Vis. Sci., May 1, 2001; 42(6): 1237 - 1242. [Abstract] [Full Text] |
||||
![]() |
N. G Congdon Prevention strategies for age related cataract: present limitations and future possibilities Br. J. Ophthalmol., May 1, 2001; 85(5): 516 - 520. [Full Text] |
||||
![]() |
A. Taylor and S. Moeller Fat cat(aract) Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1417 - 1418. [Full Text] [PDF] |
||||
![]() |
D. A Schaumberg, R. J Glynn, W. G Christen, S. E Hankinson, and C. H Hennekens Relations of body fat distribution and height with cataract in men Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1495 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. West, B. Munoz, J. Istre, G. S. Rubin, S. M. Friedman, L. P. Fried, K. Bandeen-Roche, and O. D. Schein Mixed Lens Opacities and Subsequent Mortality Arch Ophthalmol, March 1, 2000; 118(3): 393 - 397. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |